SOLUNA HOLDINGS INC (SLNH)

US5835433013 - Common Stock

2.56  +0.18 (+7.56%)

After market: 2.5 -0.06 (-2.34%)

Fundamental Rating

2

Overall SLNH gets a fundamental rating of 2 out of 10. We evaluated SLNH against 280 industry peers in the Software industry. SLNH may be in some trouble as it scores bad on both profitability and health. SLNH is quite expensive at the moment. It does show a decent growth rate.



Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year SLNH has reported negative net income.
SLNH had a negative operating cash flow in the past year.
In multiple years SLNH reported negative net income over the last 5 years.
In multiple years SLNH reported negative operating cash flow during the last 5 years.

1.2 Ratios

SLNH's Return On Assets of -30.84% is on the low side compared to the rest of the industry. SLNH is outperformed by 78.39% of its industry peers.
SLNH's Return On Equity of -143.80% is on the low side compared to the rest of the industry. SLNH is outperformed by 81.32% of its industry peers.
Industry RankSector Rank
ROA -30.84%
ROE -143.8%
ROIC N/A
ROA(3y)-50.87%
ROA(5y)-24.88%
ROE(3y)-117.17%
ROE(5y)-62.01%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Gross Margin of SLNH (35.03%) is worse than 80.59% of its industry peers.
SLNH's Gross Margin has declined in the last couple of years.
SLNH does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 35.03%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.75%
GM growth 5Y-18.98%

More info and screens

1

2. Health

2.1 Basic Checks

SLNH does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for SLNH has been increased compared to 1 year ago.
Compared to 5 years ago, SLNH has more shares outstanding
SLNH has a better debt/assets ratio than last year.

2.2 Solvency

SLNH has an Altman-Z score of -3.97. This is a bad value and indicates that SLNH is not financially healthy and even has some risk of bankruptcy.
SLNH has a worse Altman-Z score (-3.97) than 84.25% of its industry peers.
A Debt/Equity ratio of 0.55 indicates that SLNH is somewhat dependend on debt financing.
SLNH has a worse Debt to Equity ratio (0.55) than 69.23% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF N/A
Altman-Z -3.97
ROIC/WACCN/A
WACC10.63%

2.3 Liquidity

SLNH has a Current Ratio of 0.59. This is a bad value and indicates that SLNH is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.59, SLNH is not doing good in the industry: 91.21% of the companies in the same industry are doing better.
A Quick Ratio of 0.59 indicates that SLNH may have some problems paying its short term obligations.
SLNH has a worse Quick ratio (0.59) than 90.84% of its industry peers.
Industry RankSector Rank
Current Ratio 0.59
Quick Ratio 0.59

More info and screens

4

3. Growth

3.1 Past

SLNH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 85.11%, which is quite impressive.
SLNH shows a strong growth in Revenue. In the last year, the Revenue has grown by 163.50%.
The Revenue has been growing by 21.19% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)85.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80.84%
Revenue 1Y (TTM)163.5%
Revenue growth 3Y227.45%
Revenue growth 5Y21.19%
Sales Q2Q%29.74%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

SLNH reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

SLNH's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. SLNH is cheaper than 73.63% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 33.31

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SLNH!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SOLUNA HOLDINGS INC

NASDAQ:SLNH (1/6/2025, 8:00:57 PM)

After market: 2.5 -0.06 (-2.34%)

2.56

+0.18 (+7.56%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-12 2024-08-12/amc
Earnings (Next)N/A N/A
Inst Owners3.4%
Inst Owner Change0%
Ins Owners32.85%
Ins Owner Change32.04%
Market Cap28.36M
Analysts0
Price TargetN/A
Short Float %4.65%
Short Ratio0.98
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.71
P/FCF N/A
P/OCF N/A
P/B 1.36
P/tB 31.91
EV/EBITDA 33.31
EPS(TTM)-8.89
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.55
FCFYN/A
OCF(TTM)-0.18
OCFYN/A
SpS3.6
BVpS1.88
TBVpS0.08
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -30.84%
ROE -143.8%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 35.03%
FCFM N/A
ROA(3y)-50.87%
ROA(5y)-24.88%
ROE(3y)-117.17%
ROE(5y)-62.01%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.75%
GM growth 5Y-18.98%
F-Score5
Asset Turnover0.41
Health
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF N/A
Debt/EBITDA 9.5
Cap/Depr 26.22%
Cap/Sales 10.28%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.59
Quick Ratio 0.59
Altman-Z -3.97
F-Score5
WACC10.63%
ROIC/WACCN/A
Cap/Depr(3y)533.81%
Cap/Depr(5y)540.56%
Cap/Sales(3y)204.65%
Cap/Sales(5y)150.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)85.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80.84%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)163.5%
Revenue growth 3Y227.45%
Revenue growth 5Y21.19%
Sales Q2Q%29.74%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y43.94%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y93.08%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-155.84%
OCF growth 3YN/A
OCF growth 5YN/A